MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on December 14, 2004; DOI: 10.1124/mol.104.007500


0026-895X/05/6703-912-922$20.00
Mol Pharmacol 67:912-922, 2005

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.007500v1
67/3/912    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hosoda, C.
Right arrow Articles by Tsujimoto, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hosoda, C.
Right arrow Articles by Tsujimoto, G.
ORIGINAL ARTICLE

Two {alpha}1-Adrenergic Receptor Subtypes Regulating the Vasopressor Response Have Differential Roles in Blood Pressure Regulation

Chihiro Hosoda, Taka-aki Koshimizu, Akito Tanoue, Yoshihisa Nasa, Ryo Oikawa, Takashi Tomabechi, Shinya Fukuda, Hitomi Shinoura, Sayuri Oshikawa, Satoshi Takeo, Tadaichi Kitamura, Susanna Cotecchia, and Gozoh Tsujimoto

Department of Molecular, Cell Pharmacology, National Research Institute for Child Health and Development, Tokyo, Japan (C.H., A.T., T.Ko., H.S., S.O.); Department of Pharmacology, Tokyo University of Pharmacy and Life Science, Horinouchi, Hachioji, Tokyo, Japan (Y.N., R.O., T.T., S.F., S.T.); Department of Urology, Faculty of Medicine, University of Tokyo, Tokyo, Japan (C.H., T.Ki.); Institut de Pharmacologie et Toxicologie, Universit de Lausanne, Lausanne, Switzerland (S.C.); and Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan (G.T.)

Abstract

To study the functional role of individual {alpha}1-adrenergic (AR) subtypes in blood pressure (BP) regulation, we used mice lacking the {alpha}1B-AR and/or {alpha}1D-AR with the same genetic background and further studied their hemodynamic and vasoconstrictive responses. Both the {alpha}1D-AR knockout and {alpha}1B-/{alpha}1D-AR double knockout mice, but not the {alpha}1B-AR knockout mice, had significantly (p < 0.05) lower levels of basal systolic and mean arterial BP than wild-type mice in nonanesthetized condition, and they showed no significant change in heart rate or in cardiac function, as assessed by echocardiogram. All mutants showed a significantly (p < 0.05) reduced catecholamine-induced pressor and vasoconstriction responses. It is noteworthy that the infusion of norepinephrine did not elicit any pressor response at all in {alpha}1B-/{alpha}1D-AR double knockout mice. In an attempt to further examine {alpha}1-AR subtype, which is involved in the genesis or maintenance of hypertension, BP after salt loading was monitored by tail-cuff readings and confirmed at the endpoint by direct intra-arterial recording. After salt loading, {alpha}1B-AR knockout mice developed a comparable level of hypertension to wild-type mice, whereas mice lacking {alpha}1D-AR had significantly (p < 0.05) attenuated BP and lower levels of circulating catecholamines. Our data indicated that {alpha}1B- and {alpha}1D-AR subtypes participate cooperatively in BP regulation; however, the deletion of the functional {alpha}1D-AR, not {alpha}1B-AR, leads to an antihypertensive effect. The study shows differential contributions of {alpha}1B- and {alpha}1D-ARs in BP regulation.


Received for publication September 22, 2004.

Accepted for publication December 14, 2004.

Address correspondence to: Dr. Gozoh Tsujimoto, Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University Faculty of Pharmaceutical Sciences, Kyoto University, Yoshida Shimoadachi-cho, Sakyo-ku, Kyoto 606-8501, Japan. E-mail: gtsujimoto{at}nch.go.jp




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
A. Gericke, P. Martinka, I. Nazarenko, P. B. Persson, and A. Patzak
Impact of {alpha}1-adrenoceptor expression on contractile properties of vascular smooth muscle cells
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1215 - R1221.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Hosoda, M. Hiroyama, A. Sanbe, J.-i. Birumachi, T. Kitamura, S. Cotecchia, P. C. Simpson, G. Tsujimoto, and A. Tanoue
Blockade of both {alpha}1A- and {alpha}1B-adrenergic receptor subtype signaling is required to inhibit neointimal formation in the mouse femoral artery
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H514 - H519.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. E. Faber, C. L. Szymeczek, S. Cotecchia, S. A. Thomas, A. Tanoue, G. Tsujimoto, and H. Zhang
{alpha}1-Adrenoceptor-dependent vascular hypertrophy and remodeling in murine hypoxic pulmonary hypertension
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2316 - H2323.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
L. J. Mullins, M. A. Bailey, and J. J. Mullins
Hypertension, Kidney, and Transgenics: A Fresh Perspective
Physiol Rev, April 1, 2006; 86(2): 709 - 746.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
C. Hague, S. E. Lee, Z. Chen, S. C. Prinster, R. A. Hall, and K. P. Minneman
Heterodimers of {alpha}1B- and {alpha}1D-Adrenergic Receptors Form a Single Functional Entity
Mol. Pharmacol., January 1, 2006; 69(1): 45 - 55.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Erami, H. Zhang, A. Tanoue, G. Tsujimoto, S. A. Thomas, and J. E. Faber
Adrenergic catecholamine trophic activity contributes to flow-mediated arterial remodeling
Am J Physiol Heart Circ Physiol, August 1, 2005; 289(2): H744 - H753.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Masuki, T. Todo, Y. Nakano, H. Okamura, and H. Nose
Reduced {alpha}-adrenoceptor responsiveness and enhanced baroreflex sensitivity in Cry-deficient mice lacking a biological clock
J. Physiol., July 1, 2005; 566(1): 213 - 224.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2005 by the American Society for Pharmacology and Experimental Therapeutics